Trial intelligence / Profile preview

Ultrasound-Guided Intermediate Cervical Plexus Block vs. Erector Spinae Plane Block for Anterior Cervical Spine Surgery

NCT06867510Phase 3Not yet recruiting

Sponsor
Tanta University
Start
Apr 2025
Primary completion
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Tanta University. Planned start Apr 2025; status: not yet recruiting.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06867510.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06867510.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call